Sugentech Inc.
KOE: 253840.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Jin Mi
- Employees
- 145
- Headquarters
- Daejeon, South Korea
- IPO year
- 2017
- Market cap
- ₩95.6B
- Website
- http://sugentech.com
Loading 253840…
Loading profile data…Frequently asked questions about 253840
What does Sugentech Inc. (253840.KQ) do?
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers Multiplex BLOT disease diagnostic devices, such as immunoblot processor, semi and full automation, and molecular diagnostic systems, as well as test i...
Where does 253840.KQ trade?
Sugentech Inc. (253840.KQ) trades on the KOSDAQ.
What sector is 253840.KQ in?
Sugentech Inc. (253840.KQ) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Sugentech Inc.?
Jin Mi is the chief executive officer of Sugentech Inc. (253840.KQ).
Where is Sugentech Inc. headquartered?
Sugentech Inc. is headquartered in South Korea.
Does 253840.KQ pay a dividend?
Yes — Sugentech Inc. (253840.KQ) paid a trailing twelve-month dividend of KRW 150.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 253840.KQ go public?
Sugentech Inc. (253840.KQ) completed its initial public offering in 2017.